{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:25:55Z","timestamp":1790760355454,"version":"4.1.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK124133"],"award-info":[{"award-number":["DK124133"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK112978"],"award-info":[{"award-number":["DK112978"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK56621"],"award-info":[{"award-number":["DK56621"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM007280"],"award-info":[{"award-number":["T32 GM007280"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background &amp; aim<\/jats:title>\n                    <jats:p>Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD) that is responsible for a growing fraction of cirrhosis and liver cancer cases worldwide. Changes in the gut microbiome have been implicated in NASH pathogenesis, but the lack of suitable murine models has been a barrier to progress. We have therefore characterized the microbiome in a well-validated murine NASH model to establish its value in modeling human disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The composition of intestinal microbiota was monitored in mice on a 12- or 24-week NASH protocol consisting of high fat, high sugar Western Diet (WD) plus once weekly i.p injection of low-dose CCl\n                      <jats:sub>4<\/jats:sub>\n                      . Additional mice were subjected to WD-only or CCl\n                      <jats:sub>4<\/jats:sub>\n                      -only conditions to assess the independent effect of these variables on the microbiome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There was substantial remodeling of the intestinal microbiome in NASH mice, characterized by declines in both species diversity and bacterial abundance. Based on changes to beta diversity, microbiota from NASH mice clustered separately from controls in principal coordinate analyses. A comparison between WD-only and CCl\n                      <jats:sub>4<\/jats:sub>\n                      -only controls with the NASH model identified WD as the primary driver of early changes to the microbiome, resulting in loss of diversity within the 1\n                      <jats:sup>st<\/jats:sup>\n                      week. A NASH signature emerged progressively at weeks 6 and 12, including, most notably, a reproducible bloom of the Firmicute order\n                      <jats:italic>Erysipelotrichales<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We have established a valuable model to study the role of gut microbes in NASH, enabling us to identify a new NASH gut microbiome signature.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0244763","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T14:02:41Z","timestamp":1609768961000},"page":"e0244763","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4181-8904","authenticated-orcid":true,"given":"James K.","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipankar","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua N.","family":"Borgerding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Isabel","family":"Fiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah J.","family":"Faith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"issue":"1","key":"pone.0244763.ref001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Z Younossi","year":"2018","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"3","key":"pone.0244763.ref002","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease\u2014A global public health perspective","volume":"70","author":"ZM Younossi","year":"2019","journal-title":"Journal of hepatology"},{"issue":"7","key":"pone.0244763.ref003","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"SL Friedman","year":"2018","journal-title":"Nature Medicine"},{"issue":"8","key":"pone.0244763.ref004","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1053\/j.gastro.2016.02.073","article-title":"Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?","volume":"150","author":"NS Betrapally","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"pone.0244763.ref005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.chom.2020.07.007","article-title":"Microbiota and Fatty Liver Disease\u2014the Known, the Unknown, and the Future","volume":"28","author":"S Lang","year":"2020","journal-title":"Cell Host and Microbe"},{"issue":"6","key":"pone.0244763.ref006","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"B Schnabl","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"pone.0244763.ref007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06929-0","article-title":"The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD","volume":"9","author":"TK Soderborg","year":"2018","journal-title":"Nature Communications"},{"issue":"7122","key":"pone.0244763.ref008","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"PJ Turnbaugh","year":"2006","journal-title":"Nature"},{"issue":"7","key":"pone.0244763.ref009","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1172\/JCI93465","article-title":"Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis","volume":"127","author":"C Caussy","year":"2017","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"pone.0244763.ref010","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.28674","article-title":"Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study","volume":"64","author":"J Cui","year":"2016","journal-title":"Hepatology"},{"issue":"7","key":"pone.0244763.ref011","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2015.08.011","article-title":"Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study","volume":"149","author":"R Loomba","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"pone.0244763.ref012","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"L Miele","year":"2009","journal-title":"Hepatology"},{"issue":"6","key":"pone.0244763.ref013","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"J Mouries","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"5","key":"pone.0244763.ref014","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.1096\/fj.201902687R","article-title":"Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis","volume":"34","author":"B Gupta","year":"2020","journal-title":"FASEB Journal"},{"issue":"3","key":"pone.0244763.ref015","doi-asserted-by":"crossref","first-page":"e00131","DOI":"10.14309\/ctg.0000000000000131","article-title":"Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC","volume":"11","author":"S Sydor","year":"2020","journal-title":"Clinical and translational gastroenterology"},{"issue":"3","key":"pone.0244763.ref016","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1152\/ajpgi.00163.2009","article-title":"Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice","volume":"300","author":"T Csak","year":"2011","journal-title":"American Journal of Physiology\u2014Gastrointestinal and Liver Physiology"},{"issue":"8","key":"pone.0244763.ref017","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1053\/j.gastro.2020.02.033","article-title":"TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits \u03b3-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice","volume":"158","author":"M Zhao","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"pone.0244763.ref018","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","article-title":"Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae","volume":"30","author":"J Yuan","year":"2019","journal-title":"Cell Metabolism"},{"issue":"4","key":"pone.0244763.ref019","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.28696","article-title":"Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice","volume":"64","author":"DJ Kang","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"pone.0244763.ref020","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease","volume":"25","author":"R Loomba","year":"2017","journal-title":"Cell Metabolism"},{"key":"pone.0244763.ref021","first-page":"1","article-title":"A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis","volume":"2020","author":"TG Oh","journal-title":"Cell Metabolism"},{"issue":"3","key":"pone.0244763.ref022","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/19490976.2019.1681861","article-title":"Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis","volume":"11","author":"S Astbury","year":"2020","journal-title":"Gut Microbes"},{"issue":"1","key":"pone.0244763.ref023","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09455-9","article-title":"A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease","volume":"10","author":"C Caussy","year":"2019","journal-title":"Nature Communications"},{"issue":"2","key":"pone.0244763.ref024","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"T Tsuchida","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"6","key":"pone.0244763.ref025","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"DE Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"pone.0244763.ref026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.40553","article-title":"Gut microbiota density influences host physiology and is shaped by host and microbial factors","volume":"8","author":"EJ Contijoch","year":"2019","journal-title":"eLife"},{"key":"pone.0244763.ref027","first-page":"1476","author":"LA David","journal-title":"Diet rapidly and reproducibly alters the human gut microbiome"},{"issue":"3","key":"pone.0244763.ref028","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2010.11.049","article-title":"Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency","volume":"140","author":"MD Spencer","year":"2011","journal-title":"Gastroenterology"},{"issue":"NOV","key":"pone.0244763.ref029","first-page":"1","article-title":"Insights into the role of Erysipelotrichaceae in the human host","volume":"5","author":"NO Kaakoush","year":"2015","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"pone.0244763.ref030","first-page":"1932","author":"JK Harris","journal-title":"Specific microbiome changes in a mouse model of parenteral nutrition associated liver injury and intestinal inflammation"},{"issue":"1","key":"pone.0244763.ref031","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40168-016-0189-7","article-title":"Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functions.","volume":"4","author":"M Estaki","year":"2016","journal-title":"Microbiome"},{"issue":"4","key":"pone.0244763.ref032","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrmicro2540","article-title":"Unravelling the effects of the environment and host genotype on the gut microbiome","volume":"9","author":"A Spor","year":"2011","journal-title":"Nature Reviews Microbiology"},{"issue":"1","key":"pone.0244763.ref033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/dmm.017400","article-title":"How informative is the mouse for human gut microbiota research?","volume":"8","author":"TLA Nguyen","year":"2015","journal-title":"DMM Disease Models and Mechanisms"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0244763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T14:03:44Z","timestamp":1609769024000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0244763"}},"subtitle":[],"editor":[{"given":"Gianfranco D.","family":"Alpini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0244763","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]}}}